![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Monday, May 11, 2020 8:24:10 AM
What you have here is a bunch of excuses. Every one of the dozens of calculations and factors she mentions is a built-in excuse for further delay, and that is what we are going to get. The statement below sounds exactly the same as statements she has made many times previously. How many times have they promised TLD? How many times have they delivered? Yeah, nothing has changed, folks. They don't actually plan to release this data because it doesn't show what they want it to show. Just watch. We'll get an announcement of data lock probably in June (because they never meet a deadline), and then it will be back to radio silence for months. They are lying, and they are playing games. Just ask Dr. Duffy. BTW, has anyone bothered to call Dr. Duffy? Seems like he would be an excellent source to shed some light on what is really going on at NWBO, and a simple phone call is all it would take.
“The steps that happen after that, there’s been a bit of confusion, folks have asked questions about how does the process work? What will happen at datalock, as soon as we have datalock the independent statisticians, we are not doing any of the calculations or analyses. They’re all being done by independent statisticians. They will gain access to the clinical trial database. Meaning they will have then access to all of the raw data and they will start doing all the calculations that everybody wants to see. They’ll calculate the median survival and the percent of survival at various time points and all of those various calculations. They will also do a lot of statistical calculations, t-values, hazard ratios, confidence intervals, etc. They will develop graphs and tables, all of the work that will take the raw data points and present them in a way that tells us the results. The clinical outcomes from this trial. That work will take several weeks. We anticipate that work will be taking place in June and as soon as the work by the statisticians is done and delivered to the company, that’s when we the company will become unblinded.
“We will not become unblinded at the time of datalock when the statisticians gain access to the database full of raw datapoints. We will become unblinded when the results of the statisticians, all their calculations and arithmetic gets delivered to us. Then as a final step we will, of course, consult with all of our medical experts. The steering committee of the Phase III trial, the Scientific Advisory Board, etc. And gather any questions or comments that those experts may have and make sure that those are addressed in preparing the information for public presentation. And as soon as that process with the medical experts is done, we will be announcing the results.
Recent NWBO News
- Biophma Announces Exclusive In License for Dendritic Cell Technology, Sending Shares Higher • AllPennyStocks.com • 06/17/2024 04:40:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/04/2024 09:11:16 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 06/03/2024 09:22:55 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 05/22/2024 08:13:36 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/10/2024 09:04:57 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/01/2024 10:04:38 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/02/2023 01:31:35 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/16/2023 10:11:54 PM
- Epazz, Inc. (OTC Pink: EPAZ) ZenaDrone Demonstration to Defense Departments of UAE and Saudi Arabia • InvestorsHub NewsWire • 11/15/2023 12:19:31 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/09/2023 09:30:39 PM
- Epazz, Inc. (OTC Pink: EPAZ) US Navy Collaboration ZenaDrone 1000 • InvestorsHub NewsWire • 11/09/2023 01:00:34 PM
- Epazz, Inc. (OTC Pink: EPAZ) US Navy Collaboration ZenaDrone 1000 Extreme Weather Demo • InvestorsHub NewsWire • 11/07/2023 12:29:43 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/09/2023 08:36:14 PM
Last Shot Hydration Drink Announced as Official Sponsor of Red River Athletic Conference • EQLB • Jun 20, 2024 2:38 PM
ATWEC Announces Major Acquisition and Lays Out Strategic Growth Plans • ATWT • Jun 20, 2024 7:09 AM
North Bay Resources Announces Composite Assays of 0.53 and 0.44 Troy Ounces per Ton Gold in Trenches B + C at Fran Gold, British Columbia • NBRI • Jun 18, 2024 9:18 AM
VAYK Assembling New Management Team for $64 Billion Domestic Market • VAYK • Jun 18, 2024 9:00 AM
Fifty 1 Labs, Inc Announces Acquisition of Drago Knives, LLC • CAFI • Jun 18, 2024 8:45 AM
Hydromer Announces Attainment of ISO 13485 Certification • HYDI • Jun 17, 2024 9:22 AM